Related Experiment Video
Updated: May 4, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
Physical activity enhancement to a behavioral weight loss program for severely obese individuals: A preliminary
Jessica L Unick1, Kevin C O'Leary1, Dale S Bond1
1Weight Control and Diabetes Research Center, The Miriam Hospital and Brown Medical School, Providence, RI.
Abstract:
Severe obesity is characterized by low physical activity (PA) and interventions to enhance PA are needed. Participants (45.0 ± 3.9 kg/m2) were randomized to a 6-month standard behavioral weight loss program (SBWL; n = 14) or SBWL+technology (SBWL+TECH; n = 15). Both groups received identical SBWL treatment and SBWL+TECH also received a wearable PA monitor, providing "real-time" feedback, and website access to monitor energy balance. 6-month retention was similar between groups (SBWL: 12/13 versus SBWL+TECH: 11/14 completers; P = 0.19) and adherence to wearing the armband was excellent (91.3% of days). Although differences in PA between groups did not meet conventional thresholds of significance, SBWL+TECH increased their moderate-to-vigorous intensity PA by 132.9±216.8 min/week, which was 3 times greater than SBWL (44.8±124.3 min/week; P = 0.27; Cohen's d = 0.50). There was a trend for SBWL+TECH to self-monitor for a greater proportion of days compared to SBWL (86.2±21.4% versus 71.5±19.4%; P = 0.098; Cohen's d = 0.72). The difference in weight loss between groups was modest (SBWL+TECH: -10.0 ± 7.1% versus SBWL: -7.8 ± 6.7%; P = 0.46). These preliminary findings suggest that PA monitors may be one strategy for increasing PA among the severely obese. Larger, long-term trials are needed.
More Related Videos
06:28A Chronic High-Intensity Interval Training and Diet-Induced Obesity Model to Maximize Exercise Effort and Induce Physiologic Changes in Rats
Published on: April 28, 2023
05:59Visualization of Intensity Levels to Reduce the Gap Between Self-Reported and Directly Measured Physical Activity
Published on: March 7, 2019
Related Concept Videos
Obesity
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Drug Dosing: Obese Patients